In order to truly help biotech and pharmaceutical companies in their journey from drug development to commercialization, contract development and manufacturing organisations (CDMOs) have begun to incorporate the latest innovations in all aspects of their operations.
Whether this implementation happens in science, in manufacturing equipment, or communication technologies, CDMOs are pushing the boundaries and making changes. One area that may be less tangible is the management of the relationship with their customers, as well as the management of the customers’ programs. Sponsor companies and their suppliers are starting to work together more collaboratively than ever before, to ensure positive outcomes. Successful delivery of a program on time, first time, translates into time and cost savings. The main driving force behind this evolutional change revolves around the need for reduction of drug development costs which in turn opens new avenues for better patient care. However, there are still companies hesitant to enter into completely open and collaborative partnerships. Some CDMOs, thus, have taken it upon themselves to incorporate leading edge solutions to help streamline project and customer management. Uquifa, a leading CDMO headquartered in Barcelona, Spain, further raises the bar in the delivery of pharmaceutical ingredients with its fit-for-purpose small molecule development and manufacturing capabilities and its new approach to project management.